Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
티움바이오 logo

티움바이오

Recent Finacing

Equity

Recent Raise

$16.4M

TiumBio is a South Korean biotech spin-off from SK Chemicals developing novel small-molecule and biologic drugs for endometriosis, diabetes, cancer, and hemophilia.

Kyonggi-do, South Korea
51-100
Publicly Traded
tiumbio.com

Highlights

Focus Areas

Health Care
Health Diagnostics
Medical

Financials

$16.4M

Total Raised

1

Funding round


Team

Upgrade to view the team

See the team members at 티움바이오.